Pricing for childhood vaccines referencing the current Center for Disease Control and Preventions (CDC) Federal Contract for Vaccine…

Merck Sharp & Dohme Corp has been awarded a Texas state contract (No. HHSTX-6-0000407449) effective June 23, 2026, for the provision of childhood vaccines and related biological products. The contract pricing references the Centers for Disease Control and Prevention Federal Contract for Vaccine and Biologicals (CDC Federal Contract No. 75D30126D20729) and is awarded under the authority of Texas Government Code Section 2155.144 for goods and services acquired on behalf of clients served by state agency programs. The contract encompasses multiple vaccine categories including diphtheria and tetanus toxoids absorbed, rubella virus vaccine, and tetanus vaccine, as well as additional therapeutic agents classified under serums, toxoids, and vaccines.

The contract is procured for the benefit of Texas program beneficiaries and does not specify a defined contract period of performance or cumulative contract value in the award documentation. The procurement falls under the National Institute of Governmental Purchasing classification for serums, toxoids, and vaccines (NIGP Code 26980) and encompasses multiple United Nations Standard Products and Services Code classifications related to immunological and biological products. As the prime contractor, Merck Sharp & Dohme Corp assumes full responsibility for delivery and compliance with all applicable contractual terms and CDC pricing standards.